Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease

Stopped Awaiting response from FDA as to status of parenteral ascorbic acid manufactured by Bioniche (Ireland).

Conditions

• Sarcoma
• Adenocarcinoma
• Carcinoma
• Multiple Myeloma
• Desmoplastic Small Round Cell Tumor

Interventions

• DRUG: Ascorbic acid (vitamin C)

Sponsor

Situs Cancer Research Center